SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-018981
Filing Date
2022-12-27
Accepted
2022-12-27 16:01:29
Documents
7
Period of Report
2022-12-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20221227xpre14a.htm PRE 14A 927270
2 GRAPHIC tmb-20221227xpre14a004.jpg GRAPHIC 1786
3 GRAPHIC tmb-20221227xpre14a002.jpg GRAPHIC 672
4 GRAPHIC tmb-20221227xpre14a003.jpg GRAPHIC 672
5 GRAPHIC tmb-20221227xpre14a009.jpg GRAPHIC 133850
6 GRAPHIC tmb-20221227xpre14a008.jpg GRAPHIC 98268
7 GRAPHIC tmb-20221227xpre14a006.jpg GRAPHIC 733
  Complete submission text file 0001558370-22-018981.txt   1254400
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39619 | Film No.: 221490307
SIC: 2836 Biological Products, (No Diagnostic Substances)